Improved vigilance after sodium oxybate treatment in narcolepsy: a comparison between in-field and in-laboratory measurements

Journal of Sleep Research

Volumn 25, Issue 4, 2016, Pages 486-496

  van Schie, Mojca K M ^a   Werth, Esther ^b   Lammers, Gert Jan ^a   Overeem, Sebastiaan ^c,d   Baumann, Christian R ^b   Fronczek, Rolf ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^d EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

narcolepsy; sleepiness; sustained attention; vigilance

Indexed keywords

OXYBATE SODIUM;

ACTIMETRY; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MAINTENANCE OF WAKEFULNESS TEST; MEASUREMENT ERROR; MONITORING; NARCOLEPSY; OBSERVATIONAL STUDY; OXFORD SLEEP RESISTANCE TEST; PERSONAL DIGITAL ASSISTANT; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PSYCHOMOTOR VIGILANCE TEST; RESPONSE TIME; SLEEP DISORDER ASSESSMENT; SUSTAINED ATTENTION TO RESPONSE TASK;

EID: 84981289587     PISSN: 09621105     EISSN: 13652869     Source Type: Journal    
DOI: 10.1111/jsr.12386     Document Type: Article

References (27)

1. American Academy of Sleep Medicine. International Classification of Sleep Disorders. Diagnostic and Coding Manual, 2nd edn. American Academy of Sleep Medicine, Westchester, IL, 2005.
2. Ancoli-Israel, S., Cole, R., Alessi, C., Chambers, M., Moorcroft, W. and Pollak, C. P. The role of actigraphy in the study of sleep and circadian rhythms. Sleep, 2003, 26: 342–392.
3. Arand, D., Bonnet, M., Hurwitz, T., Mitler, M., Rosa, R. and Sangal, R. B. The clinical use of the MSLT and MWT. Sleep, 2005, 28: 123–144.
4. Basner, M. and Dinges, D. F. Maximizing sensitivity of the psychomotor vigilance test (PVT) to sleep loss. Sleep, 2011, 34: 581–591.
5. Bennett, L. S., Stradling, J. R. and Davies, R. J. A behavioural test to assess daytime sleepiness in obstructive sleep apnoea. J. Sleep Res., 1997, 6: 142–145.
6. Bogan, R. K., Roth, T., Schwartz, J. and Miloslavsky, M. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy. J. Clin. Sleep Med., 2015, 11: 427–432.
7. Dimitrova, A., Fronczek, R., Van Der Ploeg, J. et al. Reward-seeking behavior in human narcolepsy. J. Clin. Sleep Med., 2011, 7: 293–300.
8. Doghramji, K., Mitler, M. M., Sangal, R. B. et al. A normative study of the maintenance of wakefulness test (MWT). Electroencephalogr. Clin. Neurophysiol., 1997, 103: 554–562.
9. Donjacour, C. E., Aziz, N. A., Frolich, M. et al. Sodium oxybate increases prolactin secretion in narcolepsy patients and healthy controls. Eur. J. Endocrinol., 2011, 164: 363–370.
10. Fronczek, R., Middelkoop, H. A., Van Dijk, J. G. and Lammers, G. J. Focusing on vigilance instead of sleepiness in the assessment of narcolepsy: high sensitivity of the Sustained Attention to Response Task (SART). Sleep, 2006, 29: 187–191.
11. Hoddes, E., Zarcone, V., Smythe, H., Phillips, R. and Dement, W. C. Quantification of sleepiness: a new approach. Psychophysiology, 1973, 10: 431–436.
12. Holm, S. A simple sequentially rejective multiple test procedure. Scand. J. Stat., 1979, 6: 65–70.
13. Littner, M. R., Kushida, C., Wise, M. et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep, 2005, 28: 113–121.
14. Loh, S., Lamond, N., Dorrian, J., Roach, G. and Dawson, D. The validity of psychomotor vigilance tasks of less than 10-minute duration. Behav. Res. Methods Instrum. Comput., 2004, 36: 339–346.
15. Maitre, M. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog. Neurobiol., 1997, 51: 337–361.
16. Matthias, R. and Mehl, T. S. C. Handbook of Research Methods for Studying Daily Life, 1st edn. The Guilford Press, New York, NY, 2012.
17. Moller, H. J., Devins, G. M., Shen, J. and Shapiro, C. M. Sleepiness is not the inverse of alertness: evidence from four sleep disorder patient groups. Exp. Brain Res., 2006, 173: 258–266.
18. Parasuraman, R., Warm, J. S. and See, J. E. Brain systems of vigilance. In: R. Parasuraman (Ed) The Attentive Brain. The MIT Press, Cambridge, MA, 1998: 221–256.
19. Robertson, I. H., Manly, T., Andrade, J., Baddeley, B. T. and Yiend, J. ‘Oops!’: performance correlates of everyday attentional failures in traumatic brain injured and normal subjects. Neuropsychologia, 1997, 35: 747–758.
20. The U. S. Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann. Neurol., 1998, 43: 88–97.
21. The U. S. Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology, 2000, 54: 1166–1175.
22. The U. S. Xyrem Multicenter Study Group. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep, 2002, 25: 42–49.
23. Valley, V. and Broughton, R. Daytime performance deficits and physiological vigilance in untreated patients with narcolepsy-cataplexy compared to controls. Rev. Electroencephalogr. Neurophysiol. Clin., 1981, 11: 133–139.
24. Van Schie, M. K., Thijs, R. D., Fronczek, R., Middelkoop, H. A., Lammers, G. J. and Van Dijk, J. G. Sustained attention to response task (SART) shows impaired vigilance in a spectrum of disorders of excessive daytime sleepiness. J. Sleep Res., 2012, 21: 390–395.
25. Weaver, T. E. and Cuellar, N. A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy. Sleep, 2006, 29: 1189–1194.
26. Weaver, T. E., Laizner, A. M., Evans, L. K. et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep, 1997, 20: 835–843.
27. Wilkinson, R. T. and Houghton, D. Field test of arousal: a portable reaction timer with data storage. Hum. Factors, 1982, 24: 487–493.